Sign inJoin waitlistJoin the waitlist

KK

Kathryn Kolibaba

Hematology & Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
1993–1996
Internal Medicine
1990–1993
Oregon Hlth Sci Univ Sch of Med
1986–1990

Research

Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies
Journal of Clinical Oncology · 2013 · 935 citations
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study
Blood · 2014 · 541 citations
Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-abl-positive cells
Blood · 2000 · 261 citations

JS
Jeff Sharman
8 papers
Brian Druker
6 papers
IF
Ian Flinn
6 papers
JB
John Burke
5 papers
BK
Brad Kahl
3 papers
LK
Leonard Klein
3 papers
AC
Andy Chen
2 papers
CY
Christopher Yasenchak
2 papers
EK
Edwin Kingsley
2 papers
GS
Gilles Salles
2 papers
MS
Marshall Schreeder
2 papers
MB
Michael Boxer
2 papers